Related by context. All words. (Click for frequent words.) 70 Camvia 69 Phenoptin 68 ruxolitinib 68 Allovectin 7 R 68 MOZOBIL 68 JAK inhibitor 67 valopicitabine 67 elotuzumab 67 MyVax 67 otelixizumab 67 StaphVAX 67 BLA filing 67 HuMax CD4 67 Civacir 66 orBec 66 Mozobil 66 lumiliximab 66 Troxatyl 66 oral ridaforolimus 66 talactoferrin 66 Cinryze ™ 66 Evoltra ® 66 Allovectin 7 65 HepeX B 65 Nuvion 65 NV1FGF 65 AzaSite Plus 65 Amrubicin 65 GALNS 65 omacetaxine mepesuccinate 65 UPLYSO 65 Allovectin 7 ® 65 phase IIb clinical 65 Velcade bortezomib 65 registrational 65 Firazyr 65 Icatibant 65 PrevOnco 65 Panzem 65 pradefovir 65 Increlex TM 65 Diamyd ® 65 Aplidin 65 Archexin 65 Marqibo 65 EOquin 65 Onconase 64 phase IIa clinical 64 mipomersen 64 rilonacept 64 PEG PAL 64 bardoxolone 64 HuLuc# 64 alvespimycin 64 reslizumab 64 PRT# 64 ocrelizumab 64 CMV vaccine 64 AERx iDMS 64 BLA submission 64 AQ4N 64 XmAb# 64 IMA# 64 SinuNase 64 Virulizin ® 64 tafamidis 64 YONDELIS 64 SEBIVO 64 ganetespib 64 Hedgehog antagonist 64 confirmatory Phase III 64 Dacogen injection 64 PANVAC VF 64 ularitide 64 dexanabinol 64 initiate Phase 1b 64 Alzhemed TM 64 Virulizin R 64 TELINTRA 64 Vitaxin 64 Telintra 64 Orathecin 63 MAA submission 63 Fibrillex TM 63 MyVax ® 63 amrubicin 63 dirucotide 63 Phase Ib study 63 Behcet uveitis 63 Insegia 63 PDE4 inhibitor 63 DPX Survivac 63 PROMACTA 63 SNT MC# 63 Aryplase 63 Phase IIIb clinical 63 ELACYT 63 ofatumumab 63 MAXY alpha 63 alvimopan 63 IND submission 63 ATryn R 63 Ocrelizumab 63 Fodosine 63 ATryn ® 63 FOLOTYN ® 63 TOLAMBA 63 Desmoteplase 63 eltrombopag 63 pomalidomide 63 lomitapide 63 FOLOTYN 63 #D#C# 63 INCB# [001] 63 Factor VIIa 63 Rhucin 63 TYZEKA 63 phase IIa 63 Zalbin 63 Viramidine 63 Cinryze TM 63 Corlux 63 Nabi HB 63 RIGScan CR 63 dacetuzumab 63 Personalized Immunotherapy 63 Cinryze 63 Targretin 63 CRMD# 63 Aflibercept 63 zileuton CR 63 BAY #-# 63 INCB# [002] 63 ambrisentan 63 Rhucin ® 63 Gleevec imatinib mesylate 63 ponatinib 63 rALLy trial 63 PREOS R 63 HuMax CD# 63 glufosfamide 63 tanespimycin 63 Amigal 63 eniluracil 63 oral methylnaltrexone 63 phase IIb trial 63 MYDICAR ® 63 Tocosol Paclitaxel 63 Genz # 62 ATL# [001] 62 refractory Hodgkin lymphoma 62 Tavocept 62 MAXY G# 62 Azixa 62 MYDICAR 62 celgosivir 62 LidoPAIN SP 62 TBC# 62 MYLOTARG 62 atacicept 62 pralatrexate 62 BiovaxID 62 Zerenex 62 Altastaph 62 Surfaxin LS 62 faropenem 62 GLP toxicology studies 62 Bicifadine 62 torezolid phosphate 62 Sulonex 62 Cethromycin 62 Annamycin 62 Targretin capsules 62 HoFH 62 rALLy 62 cinacalcet HCl 62 PLK1 SNALP 62 budesonide foam 62 MAGE A3 ASCI 62 Bezielle 62 Advexin 62 Azedra 62 registrational trial 62 clofarabine 62 PEG SN# 62 Phase 2a trial 62 terlipressin 62 R sorafenib tablets 62 Phase #b/#a clinical 62 TOCOSOL Paclitaxel 62 Arcalyst 62 Shigamabs ® 62 Ilaris 62 tolevamer 62 oxymorphone ER 62 Omigard 62 dalbavancin 62 Fibrillex 62 rhThrombin 62 Zelrix 62 EndoTAG TM -1 62 CD# antibody [001] 62 ALN RSV# 62 Vectibix panitumumab 62 EOquin TM 62 MyVax R 62 AMD# [003] 62 OHR/AVR# 62 Xanafide 62 samalizumab 62 Oncophage 62 Pimavanserin 62 darapladib 62 Specifid 62 Urocidin 62 BRIM3 62 TREANDA 62 oral prodrug 62 initiate Phase Ib 62 multiple myeloma MM 62 lintuzumab 62 Kynapid 62 volociximab 62 Mepact 62 BENLYSTA 62 Kepivance 62 zalutumumab 62 cancer immunotherapies 62 Ceplene 62 OMAPRO 62 incyclinide 62 TRISENOX 62 T Pred 62 albinterferon alfa 2b 61 Fabry Disease 61 Trofex 61 HQK 61 vemurafenib 61 Phase #b/#a 61 Ketotransdel 61 tremelimumab 61 MAXY VII 61 PREOS 61 Loramyc R 61 HGS# 61 Riquent 61 BrachySil TM 61 AVN# [001] 61 Advagraf 61 ProSavin 61 DXL# 61 ALN PCS 61 forodesine 61 tamibarotene 61 hematological cancers 61 TransVax TM 61 SPRYCEL ® 61 carfilzomib 61 Kuvan 61 ONCONASE 61 Exherin TM 61 Stedivaze 61 MethyPatch 61 BRAF inhibitor 61 riociguat 61 investigational humanized monoclonal antibody 61 StaphVAX R 61 receptor tyrosine kinase inhibitor 61 Phase 2b trial 61 AeroLEF TM 61 Veronate 61 proteasome inhibitor 61 IL# PE#QQR 61 Fx #A 61 Viprinex TM 61 SUCCEED trial 61 Octreolin 61 Benlysta belimumab 61 Mipomersen 61 rhFVIIa 61 bosutinib 61 gastrointestinal stromal tumors 61 Telatinib 61 LBH# 61 TKM ApoB 61 clevudine 61 IIa trial 61 Cethrin 61 initiate Phase 2b 61 ONTAK 61 Unit Dose Budesonide 61 Ceflatonin 61 ITAX 61 Nexavar sorafenib 61 HCD# [002] 61 Panzem R NCD 61 Restanza 61 canakinumab 61 rNAPc2 61 TELCYTA 61 Prestara 61 balsalazide tablet 61 dextromethorphan quinidine 61 relapsed multiple myeloma 61 Gleevec Glivec 61 Aurexis 61 PS# [001] 61 heterozygous FH 61 orphan medicinal product 61 huC# DM4 61 octreotide implant 61 histone deacetylase HDAC inhibitor 61 Canvaxin TM 61 TransVax ™ 61 Azedra TM 61 Cushing Syndrome 61 ATIR 61 ZADAXIN ® 61 Heplisav 61 Zybrestat 61 Cellegesic 61 Pixuvri 61 CIMZIA TM 61 SEPET TM 61 vilazodone 61 lupus nephritis 61 Ambrisentan 61 StemEx R 61 Relovair 61 axitinib 61 LCP Tacro 61 pharmacokinetic PK study 61 GED aPC 61 prGCD 61 iclaprim 61 Genentech Roche 61 daclizumab 61 APTIMA HPV assay 61 oral FTY# 61 Soliris TM eculizumab 61 Certican 61 midstage trials 61 Evoltra TM 61 AGGRASTAT ® 61 KIACTA ™ 61 QLT# 61 AP# [003] 61 Catena ® 61 ADVEXIN 61 ONGLYZA ™ 61 HGS ETR1 61 refractory angina 61 omecamtiv mecarbil 61 CAMPATH 61 bafetinib 61 preclinically 61 Reverset 61 squalamine 61 omega interferon 61 ORENCIA R 61 Maribavir 61 Panitumumab 61 casopitant 61 acyclovir Lauriad R 61 ospemifene 61 Pivotal Phase III 61 RGB # 61 Phenserine 61 phase Ib 61 Mycograb 61 cannabinor 61 deforolimus 61 TMC# [002] 61 OvaRex ® MAb 61 Clolar ® 61 Dacogen 61 motesanib 61 Noxafil 61 RSR# 61 vidofludimus 61 Cimzia TM 60 midstage clinical 60 Campath ® 60 Folotyn 60 Evoltra 60 PNP inhibitor 60 LymphoStat B 60 MyVax personalized immunotherapy 60 personalized immunotherapy 60 JOULFERON 60 fidaxomicin 60 elacytarabine 60 Clolar 60 epigenetic therapies 60 regorafenib 60 Alocrest 60 Cardio Vascu Grow 60 crofelemer 60 Omacetaxine 60 anidulafungin 60 rhC1INH 60 CoFactor 60 velafermin 60 Forodesine HCl 60 motavizumab 60 EGS# 60 Numax 60 THALOMID 60 nonclinical studies 60 lucinactant 60 Xcytrin R 60 obatoclax 60 trastuzumab DM1 T DM1 60 Zenapax 60 Actimmune ® 60 FavId 60 Firdapse 60 CINTREDEKIN BESUDOTOX 60 omacetaxine 60 HGS ETR2 60 NEUPOGEN 60 Traficet EN 60 virus HCV protease inhibitor 60 R#/MEM # 60 cystinosis patients 60 nalbuphine ER 60 G#DT 60 PSMA ADC 60 Phase IIB 60 Chemophase 60 IRX 2 60 Arranon 60 PROCHYMAL 60 eprodisate Fibrillex TM 60 Neurodex 60 investigational therapies 60 dasatinib Sprycel ® 60 refractory gout 60 Phase IIb trials 60 Nabi HB Intravenous 60 Japanese Encephalitis vaccine 60 ATG Fresenius S 60 SUTENT ® 60 Zingo TM 60 Actilon 60 Northera 60 NEBIDO 60 Ceplene histamine dihydrochloride 60 clevidipine 60 Cinquil 60 CR# vcMMAE 60 BENLYSTA ® 60 Cloretazine ® 60 Pivotal Phase 60 CCX# 60 ANTEGREN 60 MORAb 60 Pruvel 60 CTAP# Capsules 60 CINOD 60 ixabepilone 60 ICA # 60 SYCREST 60 Phase #b/#a trial 60 Dacogen decitabine 60 darusentan 60 cetuximab Erbitux R 60 Acetavance 60 HEPLISAV TM 60 myelofibrosis 60 teplizumab 60 IV APAP 60 OncoVEX GM CSF 60 successfully commercialize Iluvien 60 brentuximab vedotin SGN 60 DR Cysteamine 60 Androxal TM 60 HuMax EGFr 60 Telavancin 60 ZOLINZA 60 DEB# 60 TroVax 60 ARIKACE ™ 60 AEG# 60 methylnaltrexone 60 OvaRex 60 Zensana TM 60 Anthim 60 SNT-MC#/idebenone 60 L BLP# 60 PHX# 60 indolent NHL 60 mifamurtide 60 mapatumumab 60 Nicole Onetto MD 60 telaprevir VX 60 RhuDex ® 60 Vicriviroc 60 voclosporin 60 CEQ# 60 Adentri 60 PXD# 60 Phase Ib II 60 Revlimid lenalidomide 60 teduglutide 60 IMC #B 60 brostallicin 60 Rescula 60 Cimzia ® certolizumab pegol 60 Tarceva TM 60 Lixivaptan 60 posaconazole 60 refractory chronic lymphocytic 60 davunetide 60 Raptiva ® 60 EVIZON TM 60 OXi# 60 Ostarine 60 AEGR 60 Aptivus ® 60 Glybera R 60 Torisel 60 Neulasta ® 60 Plicera 60 LAF# 60 Q#IR 60 Phase #/#a 60 JAK inhibitors 60 refractory CLL 60 Loramyc 60 sitaxsentan 60 refractory APL 60 bicifadine 60 MKC# MT 60 velaglucerase alfa 60 severe gastroparesis 60 severe hypercholesterolemia 60 Phase Ib 60 MGCD# [001] 60 Zensana 60 Sulonex TM 60 telavancin 60 Androxal ® 60 amifampridine phosphate 60 vismodegib 60 Androxal 60 Defibrotide 60 thalidomide Thalomid 60 nebivolol 60 drug ISA# 60 vernakalant oral 60 Azilect ® 60 INTERCEPT platelets 60 mertansine 60 Increlex R 60 Vernakalant 60 JAK#/JAK# inhibitor CYT# 60 Trizytek 60 Ereska 60 baminercept 60 SPARLON 60 vosaroxin 60 blinatumomab 60 NPC 1C 60 IMGN# 60 Zenvia ™ 59 TheraCIM 59 DPP4 59 recurrent glioma 59 TroVax ® 59 JZP 59 EndoTAG TM 59 Phase 1b 59 catheter occlusion 59 relapsed MM 59 Initiate Phase 59 Urocidin TM 59 Varespladib 59 PrevOnco ™ 59 Sebivo 59 mRCC 59 ATPace TM 59 metastatic renal cell carcinoma 59 UVIDEM 59 OncoVEX 59 ostarine 59 HuMax TAC 59 dimebon 59 Tesmilifene 59 enoximone 59 rALLy clinical trial 59 INT# [002] 59 CCR5 antagonist 59 zanolimumab 59 FACTIVE tablets 59 Somatuline R Autogel R 59 ASONEP 59 VEGF Trap 59 aflibercept 59 Stimuvax R 59 liprotamase 59 AMEVIVE 59 BiovaxID TM 59 Rhucin R 59 Emezine 59 HspE7 59 cobiprostone 59 Dyloject TM 59 ongoing Phase 1b 59 Itopride 59 HCV 59 Uplyso 59 Daclizumab 59 Pradefovir 59 nosocomial pneumonia 59 Omapro 59 alogliptin 59 BEXXAR 59 Epratuzumab 59 oritavancin 59 hepatitis C HCV 59 satraplatin 59 Genasense ® 59 Phase IIa trial 59 Solzira 59 Phase #/#a trial 59 selective androgen receptor modulator 59 ecallantide 59 VitiGam 59 Cetrorelix 59 Plenaxis R 59 Filgrastim 59 CONBRIZA 59 CytoFab 59 SinuNase TM 59 Zolinza 59 cancer neuroendocrine tumor 59 L MTP PE 59 Phase IIb clinical trials 59 pegfilgrastim 59 daptomycin 59 SILENOR TM 59 Carfilzomib 59 ezogabine 59 phase IIb 59 pediatric acute lymphoblastic 59 StemEx 59 HepaGam B 59 Trovax 59 RAPTIVA R 59 ASA# 59 MGN# 59 Oglemilast 59 SAR# [004] 59 Dapagliflozin 59 Maxy G# 59 Rezular 59 Rotarix ® 59 tramiprosate ALZHEMED TM 59 Aviptadil 59 Exelixis XL# 59 liposomal formulation 59 PROSTVAC VF 59 cangrelor 59 visilizumab 59 viral kinetics 59 Solazed 59 IDX# 59 Treanda 59 Biologic License Application BLA 59 dose escalation phase 59 Viprinex 59 tezampanel NGX# 59 glucokinase activator 59 Plenaxis TM 59 subcutaneous formulation 59 Phase 2b study 59 TG# [003] 59 vernakalant 59 KRN# 59 Kamada AAT 59 relapsed MCL 59 WILEX 59 Exelixis compounds 59 PEG Interferon lambda 59 denufosol 59 ENMD # 59 metastatic CRC 59 VALSTAR 59 ALN TTR 59 compound INCB# 59 Granulocyte Colony Stimulating Factor 59 JAK2 inhibitor 59 Symadex 59 Canvaxin 59 trastuzumab DM1 59 Æterna Zentaris 59 Triolex 59 thymalfasin 59 Celgene Revlimid 59 Cloretazine 59 candidate REP# 59 Nexavar ® 59 ® natalizumab 59 Phase IIb clinical 59 ROTATEQ 59 QNEXA 59 LEUKINE 59 STELARA TM 59 OFIRMEV 59 eprotirome 59 Trofex TM 59 Octreotide 59 urocortin 2 59 SILENOR 59 FRDA 59 investigational monoclonal antibody 59 CytoFabTM 59 Cancidas 59 GW# [003] 59 Zavesca r 59 Vandetanib 59 OvaRex R 59 PSN# [002] 59 Achieves Primary Endpoint 59 Phase 1a clinical 59 lorvotuzumab mertansine 59 Corgentin 59 Combidex 59 Romiplostim 59 valopicitabine NM# 59 NP2 Enkephalin 59 pirfenidone 59 ceftaroline 59 TransVax 59 ENRICH trial 59 huN# DM1 59 Onalta 59 FTY# 59 StaphVax 59 tiapamil 59 Cytolin ® 59 LymphoStat B TM 59 ATL/TV# 59 Removab 59 neurogenic orthostatic hypotension 59 OMP designation 59 GRN# 59 temsirolimus 59 Zadaxin 59 eliglustat tartrate 59 OPAXIO 59 Capesaris 59 Fludara ® 59 ILLUMINATE 59 Iluvien ® 59 Satraplatin 59 ApoB SNALP 59 Zemplar Capsules 59 nitazoxanide 59 ozarelix 59 Orphan Drug designations 59 Revlimid 59 Neo Kidney Augment 59 Somatuline Depot 59 Pirfenidone 59 RhuDex 59 Oxypurinol 59 Glufosfamide 59 tubulin inhibitor 59 TEMODAL 59 IRESSA 59 Spiegelmer ® 59 Phase 2a clinical trials 59 non metastatic osteosarcoma 59 diabetic neuropathic pain 59 NPSP# 59 lymphoma CTCL 59 Zirgan 59 Simulect 59 Zenvia TM 59 Evoltra R 59 ACZ# 59 perifosine 59 IV Busulfex 59 FVIIa 59 Lucanix R 59 CMV disease 59 TRANSDUR Bupivacaine 58 Voraxaze 58 Gleevec resistant 58 brivaracetam 58 Fast Track designation 58 Ruconest 58 Topical Interferon Alpha 2b 58 sunitinib malate 58 teriflunomide 58 CDP# 58 Vilazodone 58 Dasatinib 58 subcutaneous PRO 58 antibody MT# 58 including eniluracil ADH 58 Aloxi injection 58 Oncotype DX colon cancer 58 IMiDs 58 GLPG# 58 macitentan 58 Ceflatonin R 58 HCV protease inhibitors 58 MT#/MEDI-# 58 Phase 1b clinical 58 BNC# 58 calcineurin inhibitors 58 ISIS # 58 romiplostim 58 neratinib 58 AZILECT ® 58 cilengitide 58 Complete Response 58 Prodarsan 58 lintuzumab SGN 58 decitabine 58 TKM PLK1 58 Aurograb 58 eritoran 58 Phase Ib clinical 58 Alferon N 58 Teflaro 58 generation purine nucleoside 58 GRNVAC1 58 romidepsin 58 Rhucin ® recombinant 58 Alvesco R 58 bendamustine 58 orphan designation 58 BioNumerik 58 pegylated interferon alpha 58 gefitinib Iressa 58 Theratope 58 PhosLo 58 sargramostim 58 sapacitabine 58 Firazyr ® 58 assessing T DM1 58 Phase IIb trial 58 Crofelemer 58 NOX E# 58 Ventavis 58 Joulferon 58 Phase III Pivotal 58 CRD5 58 radiation sensitizer 58 Debio 58 icatibant 58 Onrigin 58 enzastaurin 58 RAPTIVA 58 Rezonic 58 FDA Orphan Drug 58 cardio renal 58 gastrointestinal stromal tumors GIST 58 trabectedin 58 Entereg R 58 PCA3 assay 58 rolapitant 58 CytoGam 58 investigational compounds 58 pivotal bioequivalence 58 oral taxane 58 Neo Kidney Augment ™ 58 evaluating tivozanib 58 vandetanib 58 Tolamba 58 Egrifta 58 CCR9 antagonist 58 clazosentan 58 LymphoStat B belimumab 58 sorafenib tablets 58 Genentech Rituxan 58 GSK# [002] 58 Onalta ™ 58 PDE# inhibitors 58 Irinotecan 58 masitinib 58 rThrombin 58 tivozanib 58 pexiganan 58 bortezomib Velcade 58 Balaglitazone 58 APF# 58 telbivudine 58 Biologics License Application BLA 58 ridaforolimus 58 VitiGam TM 58 Tyzeka Sebivo 58 dose cohort 58 CB2 selective receptor agonist 58 SomatoKine 58 Gattex 58 peginesatide 58 histamine dihydrochloride 58 Pazopanib 58 AA amyloidosis 58 HEPLISAV 58 chemotherapy induced neutropenia 58 DU #b 58 FluCide 58 Pegloticase 58 Lenocta TM 58 Zenpep 58 Azacitidine 58 Huntexil 58 Golimumab 58 panitumumab 58 XL# XL# 58 GGF2 58 CCR5 mAb 58 Phase IIa clinical 58 initiate Phase IIb 58 adecatumumab 58 Loramyc ® 58 LibiGel ® 58 DYNEPO 58 pegloticase 58 initiated Phase Ib 58 pertuzumab 58 FORTIS M trial 58 Velac 58 rhMBL 58 Medicinal Products EMEA 58 Serdaxin 58 Saxagliptin 58 BCX# 58 TORISEL 58 Naglazyme 58 Uvidem 58 CA9 SCAN 58 Ceplene TM 58 randomized Phase 2b 58 CYT# 58 ONCONASE R 58 pafuramidine 58 NDA submission 58 CORT # 58 TRIOLEX 58 EP #R 58 elvucitabine 58 mCRC patients 58 Telaprevir 58 Angiox ® 58 Promacta 58 Cintredekin Besudotox 58 Peginterferon alfa 2b 58 MONOVISC 58 Phase IIa trials 58 GSK# [001] 58 ARCOXIA 58 chronic myeloid leukemia CML 58 treatment naive genotype 58 ataluren 58 hoFH 58 antibody MAb 58 myelodysplastic syndromes MDS 58 evaluating Prochymal 58 Lupuzor 58 Soliris eculizumab 58 Clevudine 58 Gencaro 58 MT# MEDI 58 antisense drug 58 Cleviprex TM clevidipine 58 Locteron 58 Oracea 58 tramiprosate Alzhemed TM 58 Jevtana 58 angiogenesis inhibitor 58 dirucotide MBP# 58 inhaled AAT 58 Tarceva erlotinib 58 nucleotide analog 58 fidaxomicin Phase 58 orally administered inhibitor 58 Hematide 58 PTK ZK 58 Zemiva TM 58 DermaVir Patch 58 cethromycin 58 Saforis 58 Bronchitol 58 Sym# 58 Syncria 58 Orphan Medicinal Product 58 CIMZIA ™ 58 LHRH antagonist 58 voreloxin 58 Leukine 58 THR beta agonist 58 novel VDA molecule